Curiously, Khor et al.64 have reported promoter hypermethylation of NFE2L2, the gene encoding Nrf2, and a trend for a decrease in the intensity and percentage of Nrf2-positive cells in advanced-stage prostate cancer compared to normal prostate tissue. This evidence concerns the gene NFE2L2 and prostate carcinoma.